Henry Schein Inc (HSIC)
Industry Medical Distribution
This stock can be held in an Investment ISA and an Investment Account
Sell
$67.34
Buy
$68.17
$0.28 (+0.42%)
Prices updated at 13 Nov 2024, 22:52 EST
| Prices minimum 15 mins delay
Prices in USD
Henry Schein Inc is a provider of healthcare products and services to office-based dental, animal health and medical practitioners. The company also serves dental laboratories, government and institutional health care clinics.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2022 | 2023 |
|---|---|---|
| 12,647m | 12,339m | |
| 3,831m | 3,861m | |
| 878m | 695m | |
| 6.94 | 5.63 | |
| 538m | 416m | |
| 968m | 877m | |
| Sales, General and administrative | 2,771m | 2,956m |
| Interest expenses | 35m | 87m |
| Provision for income taxes | 170m | 120m |
| Operating expenses | 2,953m | 3,166m |
| Income before taxes | 721m | 542m |
| Net income available to common shareholders | 538m | 416m |
| 3.95 | 3.18 | |
| Net interest income | -27m | -70m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | 3.91 | 3.16 |
| Free cash flow per share | 3.7953 | 4.8796 |
| Book value/share | 27.3991 | 28.2481 |
| Debt equity ratio | 0.381602 | 0.614774 |
Balance sheet
Year | 2022 | 2023 |
|---|---|---|
| Current assets | 3,988m | 4,488m |
| Current liabilities | 2,224m | 2,683m |
| Total capital | 4,486m | 5,592m |
| Total debt | 1,497m | 2,741m |
| Total equity | 3,446m | 3,655m |
| Total non current liabilities | - | - |
| Loans | 1,040m | 1,937m |
| Total assets | 8,607m | 10,573m |
| Total liabilities | - | - |
| Cash and cash equivalents | 117m | 171m |
| Common stock | 132m | 129m |
Cash flow
Year | 2022 | 2023 |
|---|---|---|
| Cash at beginning of period | 118m | 117m |
| Cash dividends paid | - | - |
| 506m | 313m | |
| Investments (gains) losses | -276m | -1,135m |
| 117m | 171m | |
| Net income | - | - |
| 602m | 500m | |
| -96m | -187m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.
